ESSA Pharma

$6.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.30 (+4.67%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can buy or sell ESSA Pharma and other stocks, options, and ETFs commission-free!

About EPIX

ESSA Pharma, Inc. engages in the development of small molecule drugs for prostate cancer. It focuses on producing drugs which selectively block the amino-terminal domain (NTD) of the androgen receptor (AR), potentially overcoming the known AR-dependent resistance mechanisms of castration-resistant prostate cancer (CRPC), and providing CRPC patients with the potential for increased progression-free and overall survival. The company was founded by Marianne D. Sadar and Raymond J. Andersen on January 6, 2009 and is headquartered in Vancouver, Canada. The listed name for EPIX is ESSA Pharma Inc. Common Stock.

CEO
David R. Parkinson
Employees
25
Headquarters
Vancouver, British Columbia
Founded
2009
Market Cap
140.28M
Price-Earnings Ratio
Dividend Yield
Average Volume
77.61K
High Today
$6.80
Low Today
$6.43
Open Price
$6.45
Volume
146.79K
52 Week High
$8.31
52 Week Low
$3.00

Collections

EPIX Earnings

-$0.54
-$0.36
-$0.18
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Dec 17, After Hours

You May Also Like